Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Development of a facile electrochemical sensor based on GCE modified with one-step prepared PNMA-CeO 2 -fMWCNTs composite for simultaneous detection of UA and 5-FU.

Autor: Turan K; Ankara University, Faculty of Science, Department of Chemistry, Ankara, 06100, Turkey. gaydogdu@science.ankara.edu.tr., Üğe A; Kütahya Dumlupınar University, Faculty of Science and Arts, Department of Chemistry, Kütahya, 43100, Turkey., Zeybek B; Kütahya Dumlupınar University, Faculty of Science and Arts, Department of Chemistry, Kütahya, 43100, Turkey., Aydoğdu Tiğ G; Ankara University, Faculty of Science, Department of Chemistry, Ankara, 06100, Turkey. gaydogdu@science.ankara.edu.tr.

Publikováno v: Analytical methods : advancing methods and applications [Anal Methods] 2023 Dec 21; Vol. 16 (1), pp. 40-50. Date of Electronic Publication: 2023 Dec 21.

Alterations in Pre/Post Oxygenator Flows Due to Fibrin Deposition in the CardioHelp System-A Case Report.

Autor: Wahl T; Division of Perfusion Medicine, Yale New Haven Hospital, New Haven, Connecticut; and., Stokes A; Division of Perfusion Medicine, Yale New Haven Hospital, New Haven, Connecticut; and., Varner C; Division of Perfusion Medicine, Yale New Haven Hospital, New Haven, Connecticut; and., Zeybek B; Department of Anesthesiology, Yale School of Medicine, New Haven, Connecticut., Bardia A; Department of Anesthesiology, Yale School of Medicine, New Haven, Connecticut.

Publikováno v: The journal of extra-corporeal technology [J Extra Corpor Technol] 2022 Sep; Vol. 54 (3), pp. 239-241.

Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.

Autor: Roque DM; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA., Siegel ER; University of Arkansas for Medical Sciences, Little Rock, AR, USA., Buza N; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Bellone S; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Silasi DA; Division of Gynecologic Oncology, Mercy Clinic, St. Louis, MO, USA., Huang GS; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Andikyan V; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Clark M; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Azodi M; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Schwartz PE; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Rao GG; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA., Reader JC; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA., Hui P; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Tymon-Rosario JR; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Harold J; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Mauricio D; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Zeybek B; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Menderes G; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Altwerger G; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Ratner E; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Santin AD; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA. alessandro.santin@yale.edu.

Publikováno v: British journal of cancer [Br J Cancer] 2022 Jun; Vol. 126 (12), pp. 1695-1703. Date of Electronic Publication: 2022 Feb 11.

A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.

Autor: Bellone S; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Roque DM; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland., Siegel ER; Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Buza N; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Hui P; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Bonazzoli E; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Guglielmi A; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Zammataro L; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Nagarkatti N; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Zaidi S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Lee J; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea., Silasi DA; Division of Gynecologic Oncology, Mercy Clinic, St. Louis, Missouri., Huang GS; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Andikyan V; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Damast S; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Clark M; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Azodi M; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Schwartz PE; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Tymon-Rosario JR; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Harold JA; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Mauricio D; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Zeybek B; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Menderes G; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Altwerger G; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Ratner E; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Alexandrov LB; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California., Iwasaki A; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Kong Y; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Song E; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Dong W; Laboratory of Human Genetics and Genomics, Rockefeller University, New York, New York., Elvin JA; Cancer Genomics Research, Foundation Medicine, Cambridge, Massachusetts., Choi J; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea., Santin AD; Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut.

Publikováno v: Cancer [Cancer] 2022 Mar 15; Vol. 128 (6), pp. 1206-1218. Date of Electronic Publication: 2021 Dec 07.